Viral and host factors are associated with retreatment failure in hepatitis C patients receiving all-oral direct antiviral therapy.
Seiichi MawatariKohei OdaKotaro KumagaiKazuaki TabuSho IjuinKunio FujisakiYukiko InadaHirofumi UtoAkiko SaisyojiYasunari HiramineTakeshi HoriOhki TaniyamaAi ToyodomeHaruka SakaeMasafumi HashiguchiTakeshi KureKazuhiro SakuraiTsutomu TamaiAkihiro MoriuchiAkio IdoPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2020)
In addition to viral factors (e.g. Q24, L28, R30, and A92 or P32 deletion RASs), host factors (e.g. IL28B SNP) are associated with DAA retreatment failure.
Keyphrases